Integrating the serum proteomic and fecal metaproteomic to analyze the impacts of overweight/obesity on IBD: a pilot investigation

Buie MJ, Quan J, Windsor JW, Coward S, Hansen TM, King JA, et al. Global hospitalization trends for crohn’s disease and ulcerative colitis in the 21st century: a systematic review with temporal analyses. Clin Gastroenterol Hepatol. 2022. https://doi.org/10.1053/j.gastro.2021.12.094.

Article  PubMed  Google Scholar 

Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.

Article  PubMed  Google Scholar 

Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–7.

Article  PubMed  Google Scholar 

Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, et al. The cost of inflammatory bowel disease: an initiative from the crohn’s & colitis foundation. Inflamm Bowel Dis. 2020;26(1):1–10.

Article  CAS  PubMed  Google Scholar 

Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019;12(2):113–22.

Article  PubMed  PubMed Central  Google Scholar 

Bertani L, Ribaldone DG, Bellini M, Mumolo MG, Costa F. Inflammatory bowel diseases: is there a role for nutritional suggestions? Nutrients. 2021;13(4):1387.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh S, Proudfoot J, Xu R, Sandborn WJ. Impact of obesity on short- and intermediate-term outcomes in inflammatory bowel diseases: pooled analysis of placebo arms of infliximab clinical trials. Inflamm Bowel Dis. 2018;24(10):2278–84.

Article  PubMed  PubMed Central  Google Scholar 

Greuter T, Porchet F, Braga-Neto MB, Rossel JB, Biedermann L, Schreiner P, et al. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: results from the swiss inflammatory bowel disease cohort. United European Gastroenterol J. 2020;8(10):1196–207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson AM, Harmsen WS, Aniwan S, Tremaine WJ, Abu Dayyeh BK, Loftus EV. Prevalence and impact of obesity on disease-specific outcomes in a population-based cohort of patients with ulcerative colitis. J Crohns Colitis. 2021;15(11):1816–23.

Article  PubMed  PubMed Central  Google Scholar 

Jain A, Nguyen NH, Proudfoot JA, Martin CF, Sandborn WJ, Kappelman MD, et al. Impact of obesity on disease activity and patient-reported outcomes measurement information system (PROMIS) in inflammatory bowel diseases. Am J Gastroenterol. 2019;114(4):630–9.

Article  PubMed  PubMed Central  Google Scholar 

Johnson AM, Loftus EV. Obesity in inflammatory bowel disease: a review of its role in the pathogenesis, natural history, and treatment of IBD. Saudi J Gastroenterol. 2021;27(4):183–90.

Article  PubMed  PubMed Central  Google Scholar 

Dong J, Chen Y, Tang Y, Xu F, Yu C, Li Y, et al. Body mass index is associated with inflammatory bowel disease: a systematic review and meta-analysis. PLoS ONE. 2015;10(12): e0144872.

Article  PubMed  PubMed Central  Google Scholar 

Stabroth-Akil D, Leifeld L, Pfutzer R, Morgenstern J, Kruis W. The effect of body weight on the severity and clinical course of ulcerative colitis. Int J Colorectal Dis. 2015;30(2):237–42.

Article  PubMed  Google Scholar 

Nic Suibhne T, Raftery TC, McMahon O, Walsh C, O’Morain C, O’Sullivan M. High prevalence of overweight and obesity in adults with Crohn’s disease: associations with disease and lifestyle factors. J Crohns Colitis. 2013;7(7):e241–8.

Article  PubMed  Google Scholar 

Flores A, Burstein E, Cipher DJ, Feagins LA. Obesity in inflammatory bowel disease: a marker of less severe disease. Dig Dis Sci. 2015;60(8):2436–45.

Article  CAS  PubMed  Google Scholar 

Segal JP, Mullish BH, Quraishi MN, Acharjee A, Williams HRT, Iqbal T, et al. The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol. 2019;12:1756284818822250.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JWJ, Plichta D, Hogstrom L, Borren NZ, Lau H, Gregory SM, et al. Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease. Cell Host Microbe. 2021;29(8):1294–304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borren NZ, Plichta D, Joshi AD, Bonilla G, Peng V, Colizzo FP, et al. Alterations in Fecal microbiomes and serum metabolomes of fatigued patients with quiescent inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2021;19(3):519–27.

Article  CAS  PubMed  Google Scholar 

Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, et al. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun. 2018;9(1):2873.

Article  PubMed  PubMed Central  Google Scholar 

Basso D, Padoan A, D’Inca R, Arrigoni G, Scapellato ML, Contran N, et al. Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis. Clin Chem Lab Med. 2020;58(6):968–79.

Article  CAS  PubMed  Google Scholar 

Kalla R, Adams AT, Bergemalm D, Vatn S, Kennedy NA, Ricanek P, et al. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. J Crohns Colitis. 2021;15(5):699–708.

Article  CAS  PubMed  Google Scholar 

Halfvarson J, Brislawn CJ, Lamendella R, Vazquez-Baeza Y, Walters WA, Bramer LM, et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017;2:17004.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sinha SR, Haileselassie Y, Nguyen LP, Tropini C, Wang M, Becker LS, et al. Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation. Cell Host Microbe. 2020;27(4):659–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quraishi MN, Acharjee A, Beggs AD, Horniblow R, Tselepis C, Gkoutos G, et al. A Pilot Integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways. J Crohns Colitis. 2020;14(7):935–47.

Article  PubMed  PubMed Central  Google Scholar 

Lee M, Chang EB. Inflammatory bowel diseases (IBD) and the microbiome-searching the crime scene for clues. Gastroenterology. 2021;160(2):524–37.

Article  CAS  PubMed  Google Scholar 

Lehmann T, Schallert K, Vilchez-Vargas R, Benndorf D, Puttker S, Sydor S, et al. Metaproteomics of fecal samples of Crohn’s disease and ulcerative colitis. J Proteomics. 2019;201:93–103.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Bhosle A, Bae S, McIver LJ, Pishchany G, Accorsi EK, et al. Discovery of bioactive microbial gene products in inflammatory bowel disease. Nature. 2022;606(7915):754–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stejskal K, Op de Beeck J, Durnberger G, Jacobs P, Mechtler K. Ultrasensitive NanoLC-MS of subnanogram protein samples using second generation micropillar array LC technology with orbitrap exploris 480 and FAIMS PRO. Anal Chem. 2021;93(25):8704–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Sun S, Cao X, Gao J. Quantitative phosphoproteomic analysis reveals the regulatory networks of Elovl6 on lipid and glucose metabolism in Zebrafish. Int J Mol Sci. 2020;21(8):2860.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huntley RP, Sawford T, Mutowo-Meullenet P, Shypitsyna A, Bonilla C, Martin MJ, et al. The GOA database: gene ontology annotation updates for 2015. Nucleic Acids Res. 2015;43:1057–63.

Article  Google Scholar 

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.

Article  PubMed  PubMed Central  Google Scholar 

Verschaffelt P, Van Den Bossche T, Martens L, Dawyndt P, Mesuere B. Unipept desktop: a faster, more powerful metaproteomics results analysis tool. J Proteome Res. 2021;20(4):2005–9.

Article  CAS  PubMed  Google Scholar 

Rao B, Lou J, Lu H, Liang H, Li J, Zhou H, et al. Oral microbiome characteristics in patients with autoimmune hepatitis. Front Cell Infect Microbiol. 2021;11: 656674.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif